The in vivo knockdown of TRIB1 in hepatocellular carcinoma tumours in mice results in increased p53 levels, with significantly reduced tumour volume and increased cellular apoptosis relative to untreated tumours [38]. This evidence concerns the gene TP53 and hepatocellular carcinoma.